Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Statistical Model Helps Track T Cell Behavior During Cancer Immunotherapy

By LabMedica International staff writers
Posted on 19 Nov 2026

T cells play a central role in cancer immunotherapy, but their behavior can vary considerably, contributing to inconsistent treatment responses. More...

While some T cells activate effectively, others become inactive or lose their ability to respond. Although T cell receptor clonality can indicate an anticancer immune response, cells with seemingly appropriate receptors may still fail to function. To better understand these differences, researchers have developed a computational method to measure and predict T cell behavior during immunotherapy.

Researchers at Memorial Sloan Kettering Cancer Center (MSK; New York, NY, USA) developed TCRi (T cell receptor information), a statistical model designed to monitor T cell responses to immunotherapies, including therapeutic cancer vaccines. The approach links the genetic identity of individual T cell receptors with the biological states of their corresponding cells, allowing researchers to investigate how receptor sequences influence T cell behavior and how these relationships change during immunotherapy.

TCRi combines information theory with single-cell analysis to examine two key characteristics of individual T cells. The first is the genetic sequence of the T cell receptor, which determines what the cell can recognize. The second is its gene expression profile, which reflects its functional state, such as active, exhausted, or naive. By analyzing these characteristics together, the model provides insights into the relationship between T cell identity and function.

Researchers applied the model to data from more than 167,000 T cells collected from cancer patients treated with immune checkpoint inhibitors. They found that T cells from nonresponders exhibited a stronger association between receptor clonotype and functional phenotype, a pattern already present before treatment that often became more pronounced after therapy began. In contrast, responders showed a weaker association before treatment, suggesting greater flexibility in T cell states that may enable more effective immune responses following immunotherapy.

The findings were published in Nature Genetics on November 5, 2026. The work involved MSK and the Olayan Center for Cancer Vaccines at MSK. The article also notes that TCRi has been used at MSK to monitor patient responses to vaccines, including an investigational personalized pancreatic cancer vaccine.

“This approach produces a standardized measurement that lets us compare results across different studies and clinical trials,” said Benjamin Greenbaum, Ph.D., computational biologist and co-director of neoantigen discovery at the Olayan Center for Cancer Vaccines at MSK. “We have a way to learn from this data what a meaningful T cell response to an immunotherapy looks like—or doesn't.”

“This tool offers a way to get a much clearer picture of what is biologically meaningful in T cell behavior,” said Greenbaum

Related Links
Memorial Sloan Kettering Cancer Center


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New evidence now questions whether a single stool-test cutoff should be applied uniformly across all age groups.(Photo courtesy of Paul Maguire - Adobe Stock)

Study Questions Uniform Stool-Test Cutoff Across Age Groups

Colorectal cancer remains a major clinical challenge, ranking as the fourth most common cancer and the second-leading cause of cancer death in the U.K. Early-onset colorectal cancer, defined as diagnosis... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.